期刊文献+

UGT1A1基因在Gilbert综合征及Crigler-Najjar综合征发病机制中研究进展 被引量:10

Research progress of UGT1A1 gene in the pathogenesis of Gilbert and Crigler-Najjar syndromes
原文传递
导出
摘要 Gilbert综合征(Gilbert syndrome,GS)及Crigler-Najjar综合征(Crigler-Najjar syndrome,CNS)均属于先天性非溶血性黄疸,是由于人体内尿甘二磷酸葡萄糖醛酸转移酶缺乏或其活性功能低下导致胆红素代谢功能障碍性疾病。尿甘二磷酸葡萄糖醛酸转移酶基因序列的多态性表现出个体间尿甘二磷酸葡萄糖醛酸转移酶的活性差异,这是GS及CNS发病的关键因素,但目前其发病机制尚未完全明确。本文就尿甘二磷酸葡萄糖醛酸转移酶基因多态性在GS及CNS发病机制中的研究进展作一综述。 Gilbert syndrome(GS)and Crigler-Najjar syndrome(CNS)belong to congenital nonhemolytic jaundice,caused by disturbance of metabolic function of bilirubin due to deficiency or decrease in the activity of human intracorporal enzyme bilirubin uridine 5'-diphosphate-glucuronosyltransferase(UGT).UGT1A1 genetic polymorphism of UGT varies between individuals of UGT,which is the critical factor of the paroxysm of GS and CNS.But at present,its pathogenesis is not fully clear.This paper reviews the current concept and new advances on UGT gene mutation in the pathogenesis of GS and CNS.
作者 车芳 骆子义
出处 《中华实用诊断与治疗杂志》 2015年第3期219-222,共4页 Journal of Chinese Practical Diagnosis and Therapy
关键词 GILBERT综合征 Crigler-Najjar综合征 UGT1A1 基因多态性 Gilbert syndrome Crigler-Najjar syndrome UGT1A1 gene polymorphism
  • 相关文献

参考文献3

二级参考文献24

  • 1熊敏,孙汉英.Gilbert综合征四例分析并文献复习[J].临床误诊误治,2005,18(11):777-778. 被引量:2
  • 2Raijmakers MT,Jansen PL,Steegers EA,et al.Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGTlAl gene.J Hepatol,2000,33:348-351.
  • 3Toffoli G,Cecchin E,Corona G,et al.The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.J Clin Oncol,2006,24:3061-3068.
  • 4Innocenti F,Vokes EE,Ratain MJ,et al.Irinogenetics:what is the right star? J Clin Oncol,2006,24:2221-2224.
  • 5Cailliera B,Lé Pinea J,Tojcica J,et al.A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3.Pharmacogenet Genomics,2007,17:481-495.
  • 6Sun DX,Chen G,Dellinger RW,et al.Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants.Breast Cancer Res,2006,8:R50.
  • 7Mori A,Maruo Y,Iwai M,et al.UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of Clozapine.Drug Metab Dispos,2005,33:672-675.
  • 8Finel M,Li X,Gardner-Stephen D,et al.Human UDP-glucuronosyltransferase 1A5:identification,expression and activity.J Pharmacol Exp Ther,2005,315:1143-1149.
  • 9Krishnaswamy S,Hao Q,Al-Rohaimi A.UDP-glucuronosyltransferase (UGT) 1A6 pharmacogenetics:II.Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A,T181A,and R184S).J Pharmacol Exp Ther,2005,313:1340-1346.
  • 10Tankanitlert J,Morales NP,Howard TA,et al.Effects of combined UDP-glucuronosyltransferase (UGT)1A1*28 and UGT1A6*2 on paracetamol pharmacokinetics in β-thalassemia/HbE.Pharmacology,2007,79:97-103.

共引文献27

同被引文献91

  • 1国志尊,邓志华.遗传性高胆红素血症及胆汁淤积的基因诊断[J].国际遗传学杂志,2019,42(6):419-425. 被引量:3
  • 2李春娥,夏振炜,俞善昌.新生儿高胆红素血症治疗新进展[J].新生儿科杂志,2005,20(6):277-280. 被引量:72
  • 3聂青和.胆红素代谢障碍相关疾病[J].肝脏,2006,11(3):189-192. 被引量:7
  • 4中华医学会神经病学分会,中华医学会神经病学分会神经血管介入协作组,急性缺血性脑卒中介入诊疗指南撰写组.中国急性缺血性脑卒中早期血管内介入诊疗指南[J].中华神经科杂志,2015,48:356-361.
  • 5Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance [J]. Seienee, 1987,235(4792) : 1043-1046.
  • 6Weinberger B, Archer FE, Kathiravan S, et al. Effects of bilirubin on neutrophil responses in newborn infants [J ]. Neonatology, 2013,103(2) : 105-111.
  • 7Ollinger R, Bilban M, Erat A, et al. Bilirubin: a natural inhibitor of vaseular smooth muscle cell proliferation [ J ]. Circulation, 2005,112(7) : 1030-1039.
  • 8Li X, Song G, Jin Y, et al. Higher level of heine oxygenase-1 in patients with stroke than TIA[J]. J Thorae Dis, 2014, 6 (6) 772-777.
  • 9Jansen T, Hortmann M, Oelze M, et al. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidenee for direct and indirect antioxidant actions of bilirubin[J]. J Mol Cell Cardiol,2010,49(2) : 186-195.
  • 10Ben-Amotz R, Bonagura J, Velayutham M, et al.Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia/reperfusion model [J]. Front Physiol, 2014,18(5) :53.

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部